Association of patient out-of-pocket costs with prescription abandonment and delay in fills of novel oral anticancer agents Association of patient out-of-pocket costs with prescription abandonment and delay in fills of novel oral anticancer agents

Collection: Health Policy and Services Research Series Title(s): Research brief (Leonard Davis Institute of Health Economics) Author(s): Doshi, Jalpa A., author Li, Bengxiang, author Huo, Hairong, author Pettit, Amy R., author Armstrong, Katrina A., author Contributor(s): Leonard Davis Institute of Health Economics, issuing body. Publication: Philadelphia, PA : Leonard Davis Institute of Health Economics, 2018 Language(s): English Format: Text Subject(s): Antineoplastic Agents -- economics Antineoplastic Agents -- therapeutic use Drug Costs Financing, Personal -- statistics & numerical data Assessment of Medication Adherence United States Genre(s): Technical Report Abstract: High out-of-pocket (OOP) costs may limit access to novel oral cancer medications. In a retrospective study, nearly one third of patients whose OOP costs were $100 to $500 and nearly half of patients whose OOP costs were more than $2,000 failed to pick up their new prescription for an oral cancer medication, compared to 10% of patients who were required to pay less than $10 at the time of purchase. Delays in picking up prescriptions were also more frequent among patients facing higher OOP costs. Copyright: Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license. (More information) Extent: 1 online resource (1 PDF file (2 unnumbered pages)) Illustrations: Illustrations NLM Unique ID: 101720127 (See catalog record) Permanent Link: http://resource.nlm.nih.gov/101720127